Sign inGet started

Mack Randall

Insider CIK 1602336 · REPH Senior VP, Development

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
REPH Recro Pharma, Inc. M Exercise deriv2018-01-182018-01-223,100— $09,300SEC↗
REPH Recro Pharma, Inc. F Tax w/h2018-01-182018-01-22961$8.89 $8.5K33,752SEC↗
REPH Recro Pharma, Inc. M Exercise2018-01-182018-01-223,100— $034,713SEC↗
REPH Recro Pharma, Inc. A Award deriv2018-01-022018-01-0423,000— $023,000SEC↗
REPH Recro Pharma, Inc. A Award2018-01-022018-01-0411,500— $031,613SEC↗
REPH Recro Pharma, Inc. F Tax w/h2017-09-282017-10-024,649$9.04 $42.0K20,113SEC↗
REPH Recro Pharma, Inc. M Exercise2017-09-282017-10-0215,000— $024,762SEC↗
REPH Recro Pharma, Inc. A Award deriv2017-01-182017-01-2025,000— $025,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2017-01-182017-01-2012,400— $012,400SEC↗
REPH Recro Pharma, Inc. F Tax w/h2016-12-012016-12-051,892$6.48 $12.3K9,762SEC↗
REPH Recro Pharma, Inc. M Exercise2016-12-012016-12-056,100— $011,654SEC↗
REPH Recro Pharma, Inc. F Tax w/h2016-08-012016-08-032,546$9.70 $24.7K5,554SEC↗
REPH Recro Pharma, Inc. M Exercise2016-08-012016-08-036,100— $08,100SEC↗
REPH Recro Pharma, Inc. P Buy2016-05-232016-05-252,000$6.30 $12.6K2,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2015-12-162015-12-1820,000— $020,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2015-07-252015-07-2819,000— $019,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2014-12-172015-07-2819,000— $019,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2014-12-172014-12-1919,000— $019,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2014-12-172014-12-1919,000— $019,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2014-04-082014-04-0920,000— $020,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2014-03-122014-03-1320,000— $020,000SEC↗